Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine .2. The elevated plus-maze

被引:25
作者
Rodgers, RJ [1 ]
Cutler, MG [1 ]
Jackson, JE [1 ]
机构
[1] GLASGOW CALEDONIAN UNIV, DEPT BIOL SCI, GLASGOW G4 0BA, LANARK, SCOTLAND
基金
英国医学研究理事会;
关键词
anxiety; plus-maze; anxiolytics; antidepressants; buspirone; ondansetron; tianeptine; animal models; mice;
D O I
10.1016/S0091-3057(96)00242-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In followup to recent work on benzodiazepines (chlordiazepoxide) and selective monoamine reuptake inhibitors (maprotiline and fluvoxamine), the present study compares the effects of the 5-HT1A receptor partial agonist, buspirone (0.75-3.0 mg/kg), the 5-HT3 receptor antagonist, ondansetron (0.1-100 mu g/kg), and the novel antidepressant, tianeptine (2.5-10.0 mg/kg), on the behaviour of mice in the elevated plus-maze test of anxiety. Compounds were administered daily for 21 days prior to testing, and an ethological scoring technique was used to generate comprehensive behavioural profiles. Results show that subchronic treatment with ondansetron failed to influence the behaviour of mice in the plus-maze, while the Limited changes induced by buspirone could not be attributed to anxiety-related processes. In contrast, tianeptine produced unambiguous anxiogenic-like effects at the top dose tested (10.0 mg/kg), a profile that was not secondary to changes in general levels of locomotor activity or exploration. Data are discussed in relation to current pharmacotherapy of anxiety and depressive disorders, and the nature of anxiety induced by animal models. Copyright (C) 1997 Elsevier Science Inc.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 75 条
[1]   HANDLING HISTORY OF RATS MODIFIES BEHAVIORAL-EFFECTS OF DRUGS IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY [J].
ANDREWS, N ;
FILE, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) :109-112
[2]  
[Anonymous], PSYCHOPHARMACOLOGY 3
[3]  
ANSSEAU M, 1993, CRITICAL ISSUES TREA, P127
[4]  
BALLENGER JC, 1994, HDB DEPRESSION ANXIE, P275
[5]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[6]   THE INFLUENCE OF 5-HYDROXYTRYPTAMINE REUPTAKE BLOCKADE ON CCK RECEPTOR ANTAGONIST EFFECTS IN THE RAT ELEVATED ZERO-MAZE [J].
BICKERDIKE, MJ ;
MARSDEN, CA ;
DOURISH, CT ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (2-3) :403-411
[7]   ATTENUATION OF ANTIPREDATOR DEFENSIVE BEHAVIOR IN RATS FOLLOWING CHRONIC TREATMENT WITH IMIPRAMINE [J].
BLANCHARD, RJ ;
SHEPHERD, JK ;
RODGERS, RJ ;
MAGEE, L ;
BLANCHARD, DC .
PSYCHOPHARMACOLOGY, 1993, 110 (1-2) :245-253
[8]  
BRILEY M, 1986, British Journal of Pharmacology, V87, p217P
[9]  
Briley M, 1991, NEW CONCEPTS ANXIETY, P56
[10]  
CADOGAN AK, 1992, NEUROSCI LETT S, V42, pS8